×
Hero Background

Dumping Syndrome Companies

ID: MRFR/MED/3879-HCR
115 Pages
Kinjoll Dey
October 2025

Dumping syndrome is a condition characterized by rapid gastric emptying, leading to various symptoms such as nausea, vomiting, abdominal cramps, and diarrhea after consuming a meal. Several companies specialize in developing treatments and solutions for dumping syndrome.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Dumping Syndrome Market

Dumping syndrome Market

 


Latest Dumping Syndrome Companies Updates:


Medtronic's EnteroStim™ System Medtronic received FDA approval for its EnteroStim™ System in early 2023. This neurostimulation device implanted near the pyloric valve delivers electrical pulses to help regulate stomach emptying and potentially reduce dumping syndrome symptoms.


Gelesis' Plenity® Program Gelesis received FDA approval for its Plenity® Program, a novel dietary management system using swallowable, non-digestible hydrogels to induce a feeling of fullness and potentially manage postprandial symptoms like dumping.


List of Dumping Syndrome Key companies in the market:



  • Medtronic (U.S.)

  • Intuitive Surgical Inc. (U.S.)

  • TransEnterix Inc. (U.S.)

  • ALLERGAN (Republic of Ireland)

  • USGI Medical Inc. (U.S.)

  • Cousin Biotech (France)

  • GI Dynamics Inc. (U.S.)

  • Johnson & Johnson Services, Inc. (U.S.)